Collagen vascular diseases - 24/08/11
Doi : 10.1016/j.jaad.2004.04.007
Jeffrey P. Callen, MD ⁎ 
From the Division of Dermatology, University of Louisville School of Medicine USA
Reprint requests: Jeffrey P. Callen, MD, Division of Dermatology, University of Louisville School of Medicine, 310 Broadway, Louisville, KY 40292.Louisville, Kentucky
Plan
 | Funding sources: None. Conflicts of interest: The author has served as a consultant for Amgen, Biogen, Centocor, Abbott, Connetics, and Taro. He has received honorarium directly or indirectly from Amgen, Roche, and Dermik. He holds 3M, Amgen, Johnson & Johnson, and Schering-Plough stock in personal, spousal, or trust accounts for the benefit of his children. This paper includes references to uses of drugs and devices that are outside of the FDA-approved indications. |
© 2004
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 51 - N° 3
P. 427-439 - septembre 2004 Retour au numéro
Article précédent
- BOX: Bound volumes for subscribers
- Alopecia areata investigational assessment guidelines–Part II
- Elise A. Olsen, Maria K. Hordinsky, Vera H. Price, Janet L. Roberts, Jerry Shapiro, Doug Canfield, Madeleine Duvic, Lloyd E. King, Amy J. McMichael, Valerie A. Randall, Maria L. Turner, Leonard Sperling, David A. Whiting, David Norris
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?